Dr. Marder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 Rampart Way
Ste 300B
Denver, CO 80230Phone+1 303-327-4700Fax+1 303-327-4711
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 2000 - 2003
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1997 - 2000
- Tel Aviv University SacklerClass of 1997
Certifications & Licensure
- CO State Medical License 2003 - 2025
- ND State Medical License 2019 - 2020
- NY State Medical License 1998 - 2003
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
Publications & Presentations
PubMed
- 1 citationsTreatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression.V Ram Peddi, Bradley Marder, Luis Gaite, Jose Oberholzer, Ryan Goldberg
Transplantation Direct. 2023-02-01 - 113 citationsDUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.Howard Trachtman, Peter T. Nelson, Sharon G. Adler, Kirk N. Campbell, Abanti Chaudhuri
Journal of the American Society of Nephrology. 2018-11-01 - 13 citationsOpen-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.Helio Tedesco-Silva, V. Ram Peddi, Ana Sánchez-Fructuoso, Brad A. Marder, Graeme R. Russ
Transplantation Direct. 2016-03-03
Other Languages
- Spanish, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: